(Q42621681)

English

Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy : An Open-Label Pilot Study

scientific article published on January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy : An Open-Label Pilot Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

diabetic polyneuropathy

1 reference

based on heuristic

inferred from title

1

object named as

Nigishi Hotta

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

author name string

Keigo Yasuda

2

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Yasuhiro Sumita

3

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Takahisa Sano

4

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Hironobu Kakuta

5

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Makoto Nagashima

6

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Yoshinari Hayashi

7

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Masahiro Yamamoto

8

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Takaaki Wakao

9

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Makio Okuyama

10

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Masato Kobayashi

11

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Kouichi Mori

12

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

671-680

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Inhibitory effects of fidarestat on aldose reductase and aldehyde reductase activity evaluated by a new method using HPLC with post-column spectrophotometric detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensory exam with a quantitative tuning fork: rapid, sensitive and predictive of SNAP amplitude

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of predictors for foot ulceration in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How does glucose generate oxidative stress in peripheral nerve?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aldose reductase inhibitors: the end of an era or the need for different trial designs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural progression of diabetic peripheral neuropathy in the Zenarestat study population

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolrestat for Mild Diabetic Neuropathy: A 52-Week, Randomized, Placebo-Controlled Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of the C64 quantitative tuning fork and the effect of niceritrol in diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme immunoassay for erythrocyte aldose reductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17523730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200424110-00006

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42621681&oldid=1995676218"